secwatch.observer — SEC 8-K summary
======================================

Issuer:     Turnstone Biologics Corp. (—)
CIK:        0001764974
Form:       8-K
Filed at:   2025-04-01T23:59:59+00:00
Accession:  0000950170-25-047944
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud

Turnstone Biologics transfers to Nasdaq Capital Market; gets 180-day extension for bid price compliance
--------------------------------------------------------------------------------

- Turnstone Biologics received Nasdaq notice on Sep 27, 2024 for bid price below $1.00 for 30 consecutive days.
- Transferred stock listing from Nasdaq Global Market to Capital Market, effective Mar 31, 2025, under same ticker TSBX.
- Granted additional 180-day grace period until Sep 22, 2025 to regain compliance with minimum $1.00 bid price.
- Company plans reverse stock split to meet bid price requirement, subject to stockholder vote via proxy.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1764974/000095017025047944/0000950170-25-047944-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1764974/000095017025047944/tsbx-20250327.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-047944

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer